500 Global and Ashdod Port Company Unveil Batch 2 of the Ashdod Port Accelerator by 500
Ashdod Port Company, the national port of Israel, and 500 Global, one of the world’s most active multi-stage venture capital firms, today unveil the graduating Israeli startups in Batch 2 of the Ashdod Port Accelerator by 500. These startups attended a rigorous 15-week program – with additional support from a team of Deloitte Israel experts – which gave them the opportunity to work with mentors on topics ranging from growth experiments and customer discovery interviews to testing product-market fit and fundraising. The program also includes participation in an accelerated proof-of-concept process, with the potential for investment by Ashdod Port Company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230906566212/en/
Batch 2 follows a successful Batch 1 cohort that included startups deploying new technologies at the port and some receiving additional investments from the Ashdod Port Company. Batch 2 of the program will culminate with Demo Day on September 13, 2023, in Tel Aviv. It will be held in person for a curated audience of industry leaders, ecosystem players, and 500 Global network partners. Attendees will hear presentations from a diverse group of startups that are providing solutions to needs in seaport operations, and are building the next generation of companies in sectors such as Industry 4.0, Logistics, Cyber, and Security.
"The investment and support for startups are part of our long-term strategy and future growth engine, which will provide a competitive advantage to ports adapted to the future, both in Israel and around the world,” said Shaul Schneider, Chairman of the Board of Directors of Ashdod Port. “This is one of the few accelerator programs operating in ports in the world. I’m proud of the collaboration with 500 Global, which has proven itself in recent years."
"We are delighted to host our Demo Day here in Israel on September 13 and thank the 500 Global team and the port workers who accompany them,” said Eli Bar Yosef, Acting CEO of Ashdod Port. “By supporting innovation, we are turning Ashdod Port into a smart port, with the aim of spreading the word overseas as well."
“This program is a truly unique initiative, thanks to our partner’s vision and belief that technology can play a central role in modernizing the maritime industry,” said Ee Ling Lim, Executive Director of Market Launch at 500 Global. “Ashdod may be a model for other ports and we believe that it is gaining momentum as a hub for Maritime and Logistics startup founders with exciting potential. Our second batch of startups has gained a solid foundation of corporate partnerships by working with Ashdod Port, and we believe they’re set up to grow in Israel and beyond.”
"500 Global's fruitful partnership with Ashdod Port is a game-changer, positioning the port as a true leader in maritime technology locally and globally," states Tal Chen, Partner at Deloitte Advisory. "This collaborative accelerator is the real deal – it's driving the growth of the Israeli tech scene and helping Ashdod Port shine in maritime technology. After seeing the success of Batch 1 startups, we're excited about Batch 2 Demo Day and confident it'll dish out great results for the Israeli maritime industry."
Tal Chen and Deloitte bring their unique knowledge, skills and experience to the POC processes at Port Ashdod, including the accelerator. This contributes great value to the different processes from spotting promising startups to guiding them through the POC process.
This exclusive event will also feature a panel of industry experts who will share insights on the role of startups in shaping supply chain innovation, as well as trends in the maritime and logistics sector in Israel and around the world. The panel will include representatives from major logistics companies, a startup founder, 500 Global and Ashdod Port Company.
Batch 2 startups are:
- BenderTech is providing a Biometric electronic certificate ID Mobile Application, without Biometric Database, for fast entrance to multi-participant complexes, allows secure and efficient entrance.
- Briefery captures workflow events to ensure process fidelity, tracking, tracing, and analyzing your data for increased efficiency.
- Cynergy is providing a complete framework for an automated remediation ecosystem with the marketplace, SDK, and execution environment.
- Flyz Robotics is a novel autonomous Platform for Deploying Sensors, Devices and Packages on Vertical Walls and other Hard to Reach Spaces.
- Kiami is a knowledge-based technical support SaaS platform for industrial companies, enabling fast troubleshooting of machinery and product failures, and effective cross-team and cross-site knowledge collaboration sites.
- Liquid360 is a patented software that contextualizes real-time security videos and sensor data empowering security teams to act faster and more effectively.
- Magellanic is a Zero-Trust SaaS cybersecurity platform for access control of non-human identities, creating a "Unified Zero Trust Surface" for Machines, Users, APIs and Third Parties.
- Pickommerce is an autonomous pick & pack robotic station with innovative grasping technology, designed to revolutionize the e-commerce logistics landscape.
- ProxyFence is a SaaS platform for continuous API behavioral analysis and documentation.
- SeeAll is a SaaS solution that enables manufacturers to visually track their materials throughout the entire process to ensure process integrity.
- Treedis is a no-code platform that transforms industrial teams into connected workers to increase their efficiency and reduce their downtimes.
- VIDIA has developed a platform based on video analytics for quality control, safety and predictive maintenance applicable for manufacturing, energy and marine industries with working customers.
To register to attend Demo Day, please visit the event page: Supply Chain Innovation - Ashdod Port Accelerator by 500 Global Demo Day .
Ashdod Port
Ashdod Port, The Port of Israel, is the leading seaport of the State of Israel with a strategically advantageous location. Experiencing growing demand, Ashdod Port has incorporated technological advancements into its operations and has inspired other ports around the world. Ashdod Port has collaborated with other institutions and ports to establish innovation embassies that promote growth within the industry. It frequently invests in new equipment and infrastructure for private and public benefit and supports promising early-stage entrepreneurs to bolster the maritime innovation ecosystem in Israel and globally.
500 Global
500 Global is a multi-stage venture capital firm with $2.4B in assets under management as of 30 June 2023 that invests in founders building fast-growing technology companies. We focus on markets where technology, innovation, and capital can unlock long-term value and drive economic growth. We work closely with key stakeholders and advise governments on how best to support entrepreneurial ecosystems so startups can thrive. 500 Global has backed over 5,000 founders representing more than 2,800 companies operating in 80+ countries. We have invested in 35+ companies valued at over $1 billion and 160+ companies valued at over $100 million (including private, public, and exited companies). Our 190+ team members are located in over 25 countries and bring experience as entrepreneurs, investors, and operators from some of the world’s leading technology companies.
DEMO DAY IS AN INVITATION-ONLY EVENT AND THE INTENDED AUDIENCE FOR THIS EVENT IS LIMITED TO "ACCREDITED INVESTORS" AS DEFINED IN REGULATION D UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MEMBERS OF THE PRESS. ALL CONTENT PROVIDED IN THE EVENT IS PROVIDED FOR GENERAL INFORMATIONAL OR EDUCATIONAL PURPOSES ONLY AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE BY 500 GLOBAL OR ANY OF ITS AFFILIATES OR AS AN OFFER TO SELL OR SOLICITATION OF INTEREST TO PURCHASE ANY SECURITIES. NO CONTENT OR INFORMATION CONTAINED IN THE EVENT IS OR IS INTENDED AS AN OFFER TO PROVIDE ANY INVESTMENT ADVISORY SERVICE OR FINANCIAL ADVICE BY 500 GLOBAL. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT HEREIN OR IN THE EVENT BE CONSTRUED AS FUND MARKETING MATERIALS BY PROSPECTIVE INVESTORS CONSIDERING AN INVESTMENT INTO ANY 500 GLOBAL INVESTMENT FUND. INCLUSION AS A PRESENTING COMPANY IN DEMO DAY DOES NOT NECESSARILY CONFIRM INVESTMENT BY A 500 GLOBAL FUND IN SUCH COMPANY. 500 GLOBAL HAS NOT TAKEN ANY ACTIONS TO QUALIFY THE DISTRIBUTION OF THE EVENT UNDER THE SECURITIES LAWS OF ANY JURISDICTION WHERE ACTION FOR THAT PURPOSE IS REQUIRED. PERSONS OUTSIDE OF THE UNITED STATES WHO VIEW THE EVENT MUST OBSERVE ANY APPLICABLE LAWS AND RESTRICTIONS RELATING TO VIEWING THIS EVENT AND ANY RELATED ACTIVITIES OUTSIDE OF THE UNITED STATES.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230906566212/en/
Contact information
JT Eger
Communications at 500 Global
press@500.co
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
